# Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer

Source: https://onco.cc/trials/nct00316927/  
OnCo record `nct00316927` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of Aspirin, Dexamethasone and Diethylstilbestrol in Prostate cancer, run by St. Bartholomew's Hospital, completed.

## Summary

Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer is a phase 3 interventional study registered as NCT00316927 by St. Bartholomew's Hospital, with 260 participants recorded, started 2002-12. Interventions recorded: acetylsalicylic acid, dexamethasone, diethylstilbestrol. Conditions recorded: Prostate Cancer.

Linked to the drug Diethylstilbestrol because the registry names it among its interventions and Prostate cancer among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Status: completed
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT00316927
- Phase: 3
- Setting: A Randomized Phase III Trial of Dexamethasone and Aspirin (DA) Versus Dexamethasone, Diethylstilbestrol and Aspirin (DAS) in Locally Advanced or Metastatic Cancer of the Prostate - Immediate Versus Deferred Diethylstilbestrol
- Sponsor: St. Bartholomew's Hospital
- Enrolled: 260

## Sources

- ClinicalTrials.gov NCT00316927: https://clinicaltrials.gov/study/NCT00316927

## Connected records

- cancers: [Prostate cancer](https://onco.cc/cancers/prostate/)
- drugs: [Aspirin](https://onco.cc/drugs/aspirin/), [Dexamethasone](https://onco.cc/drugs/dexamethasone/), [Diethylstilbestrol](https://onco.cc/drugs/diethylstilbestrol/)

---
JSON: https://onco.cc/api/v1/entities/nct00316927.json